Benitec Limited ASX: BLT - Pfizer Granted Non-Exclusive Worldwide License to use Benitec Technology - Sue MacLeman, CEO
Sydney, Jan 5, 2007 (ABN Newswire) - Benitec Limited (ASX: BLT) - Pfizer Granted Non-Exclusive Worldwide License to use Benitec Technology - Sue MacLeman, CEO; Boardroomradio is pleased to announce that Benitec Limited (ASX: BLT) has published an audio file. The following presentation "Pfizer Granted Non-Exclusive Worldwide License to use Benitec Technology" is now available as an instant audio download to your computer. You may also transfer this information to your listening device as an IPod podcast.
The BRR service is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.
Broadcaster: Benitec Limited (ASX: BLT)
Broadcast Title: Pfizer Granted Non-Exclusive Worldwide License to use Benitec Technology
Broadcast Type: Audio stream
View the Audio stream for Benitec Limited (ASX: BLT) below.
Benitec is an Australian biotechnology company focused on licensing its extensive intellectual property portfolio and developing therapeutics to treat serious diseases using its proprietary ddRNAi technology. Its current therapeutic program is focused on Human Immunodeficiency Virus (HIV). For additional information, please visit www.benitec.com
About Boardroomradio
Sydney-based Boardroomradio (BRR) is an Investor Relations multi-media portal delivering audio webcasts to the investment community, including brokers, fund managers, analysts, and private investors.
